Clariant AG

BATS-CHIXE:CLNz Stock Report

Market Cap: CHF 3.6b

Clariant Valuation

Is CLNz undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLNz when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLNz (CHF10.92) is trading above our estimate of fair value (CHF10.19)

Significantly Below Fair Value: CLNz is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLNz?

Key metric: As CLNz is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CLNz. This is calculated by dividing CLNz's market cap by their current earnings.
What is CLNz's PE Ratio?
PE Ratio30.4x
EarningsCHF 118.00m
Market CapCHF 3.59b

Price to Earnings Ratio vs Peers

How does CLNz's PE Ratio compare to its peers?

The above table shows the PE ratio for CLNz vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.4x
JMAT Johnson Matthey
23.8x28.4%UK£2.6b
CRDA Croda International
30.4x15.1%UK£4.9b
VCT Victrex
24.9x37.8%UK£763.5m
ELM Elementis
n/a96.5%UK£796.9m
CLNZ Clariant
n/a42.8%CHF 3.6b

Price-To-Earnings vs Peers: CLNz is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the peer average (25.4x).

Price to Earnings Ratio vs Industry

How does CLNz's PE Ratio compare vs other companies in the GB Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CLNz is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the European Chemicals industry average (17.1x).

Price to Earnings Ratio vs Fair Ratio

What is CLNz's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLNz PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio30.4x
Fair PE Ratio22.3x

Price-To-Earnings vs Fair Ratio: CLNz is expensive based on its Price-To-Earnings Ratio (30.4x) compared to the estimated Fair Price-To-Earnings Ratio (22.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLNz forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 10.92
CHF 15.16
+38.8%
10.1%CHF 18.00CHF 12.50n/a17
Nov ’25CHF 12.22
CHF 15.16
+24.0%
10.1%CHF 18.00CHF 12.50n/a17
Oct ’25CHF 12.66
CHF 15.81
+24.8%
11.5%CHF 20.00CHF 12.50n/a17
Sep ’25CHF 13.42
CHF 16.01
+19.3%
11.3%CHF 20.00CHF 12.50n/a17
Aug ’25CHF 13.19
CHF 16.04
+21.6%
11.4%CHF 20.00CHF 12.00n/a17
Jul ’25CHF 14.63
CHF 15.66
+7.0%
12.7%CHF 20.00CHF 12.00n/a15
Jun ’25CHF 14.26
CHF 15.31
+7.4%
13.9%CHF 20.00CHF 12.00n/a15
May ’25CHF 13.86
CHF 15.08
+8.8%
13.3%CHF 20.00CHF 12.00n/a15
Apr ’25CHF 12.17
CHF 14.14
+16.2%
15.0%CHF 20.00CHF 11.50n/a15
Mar ’25CHF 11.29
CHF 14.54
+28.8%
14.5%CHF 20.00CHF 11.50n/a14
Feb ’25CHF 11.09
CHF 14.76
+33.1%
14.1%CHF 20.00CHF 11.50n/a14
Jan ’25CHF 12.41
CHF 15.47
+24.7%
11.3%CHF 20.00CHF 13.00n/a14
Dec ’24CHF 12.98
CHF 16.11
+24.1%
13.9%CHF 22.00CHF 13.90n/a15
Nov ’24CHF 12.93
CHF 16.11
+24.6%
13.9%CHF 22.00CHF 13.90CHF 12.2215
Oct ’24CHF 14.56
CHF 16.27
+11.8%
13.2%CHF 22.00CHF 14.00CHF 12.6615
Sep ’24CHF 15.29
CHF 16.44
+7.5%
14.6%CHF 22.00CHF 14.00CHF 13.4216
Aug ’24CHF 14.27
CHF 16.44
+15.2%
14.3%CHF 22.00CHF 14.00CHF 13.1916
Jul ’24CHF 12.94
CHF 17.97
+38.9%
14.4%CHF 24.00CHF 15.00CHF 14.6317
Jun ’24CHF 13.24
CHF 18.20
+37.5%
13.4%CHF 24.00CHF 15.00CHF 14.2617
May ’24CHF 14.90
CHF 18.57
+24.6%
12.0%CHF 24.00CHF 16.00CHF 13.8617
Apr ’24CHF 15.16
CHF 18.73
+23.5%
11.3%CHF 24.00CHF 16.00CHF 12.1717
Mar ’24CHF 15.36
CHF 18.88
+22.9%
11.1%CHF 24.00CHF 16.00CHF 11.2917
Feb ’24CHF 15.87
CHF 18.96
+19.5%
10.7%CHF 24.00CHF 16.00CHF 11.0917
Jan ’24CHF 14.69
CHF 19.08
+29.9%
10.5%CHF 24.00CHF 16.00CHF 12.4117
Dec ’23CHF 15.11
CHF 19.17
+26.9%
10.4%CHF 24.00CHF 16.00CHF 12.9817
Nov ’23CHF 15.78
CHF 19.32
+22.4%
10.3%CHF 24.00CHF 16.00CHF 12.9317

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Elkem

NOK 11.6b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 18.05

7D

0.6%

1Y

-0.6%

Navigator Company

€2.5b

Manufactures and markets pulp and paper products worldwide.

0KLO

€3.53

7D

-2.7%

1Y

-6.7%

NV Bekaert

€1.7b

Provides steel wire transformation and coating technologies worldwide.

0OQJ

€32.30

7D

-1.0%

1Y

-22.3%